Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia

• Sponsor: GAAD Medical Research Institute Inc. (Other)
• Overall Status: Unknown status
• CT.gov ID: NCT00674960
• Collaborator: (none)
• Enrollment: 0
• Location: 1
• Arm: 1
• Duration (Months): 17
• Patients Per Site Per Month: 0

Study Details

Study Description

Brief Summary

Pick's disease, also known as Pick disease,or FTD is a rare fronto-temporal neurodegenerative disease. This study will investigate the use of far infrared radiation for the control, management and treatment of Pick's disease.

Condition or Disease	Intervention/Treatment	Phase
Pick Disease of the Brain	Radiation: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)	Phase 1

Detailed Description

This disorder causes progressive destruction of nerve cells in the brain and causes tau proteins to accumulate into the "Pick bodies" that are a defining characteristic of the disease. Tau proteins are microtubule-associated proteins that are abundant in neurons in the central nervous system and are less common elsewhere.

Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system, strengthen the immune system, improve blood circulation and increase the level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain cells.

It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly lead to complete rehabilitation of people who have FTD.

Study Design

• Study Type: Interventional
• Actual Enrollment: 0 participants
• Allocation: Non-Randomized
• Intervention Model: Single Group Assignment
• Masking: None (Open Label)
• Primary Purpose: Treatment
• Official Title: Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Management, Control and Treatment of Frontotemporal Dementia (Pick's Disease)
• Study Start Date: May 1, 2008
• Anticipated Primary Completion Date: May 1, 2009
• Anticipated Study Completion Date: Oct 1, 2009

Arms and Interventions

Arm	Intervention/Treatment
Experimental: 1 Radiation: Far Infrared Radiation (5μm to 20μm wavelength)	Radiation: Radiation: Far Infrared Radiation (5μm to 20μm wavelength); Far Infrared Radiation (5μm to 20μm wavelength). Far Infrared radiation for 30 to 40 minutes per treatment session.; Other Names: Far Infrared Radiation (5μm to 20μm wavelength)

Outcome Measures

Primary Outcome Measures

1. Therapy for FTD patients [1 year]

Secondary Outcome Measures

1. Rehabilitation of FTD Patients [1 Year]

Eligibility Criteria

Criteria

• Ages Eligible for Study: N/A and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• People with Pick's Disease

Exclusion Criteria:

• None

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	The Centre for Incurable Diseases	Toronto	Ontario	Canada	M4V 1L5

Sponsors and Collaborators

• GAAD Medical Research Institute Inc.

Investigators

• Principal Investigator: Ken Nedd, M.D., GAAD Medical Research Institute Inc.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• ClinicalTrials.gov Identifier: NCT00674960
• Other Study ID Numbers: GAAD-FD-CTP1
• First Posted: May 8, 2008
• Last Update Posted: Aug 17, 2009
• Last Verified: Aug 1, 2009

• Keywords provided by , ,: Brain Atrophy, Circumscribed Lobar; Circumscribed Lobar Atrophy of the Brain; Lobar Atrophy (Brain); Pick Disease; Pick's Disease; Picks Disease of Brain
• Additional relevant MeSH terms: Dementia; Frontotemporal Dementia; Aphasia, Primary Progressive; Pick Disease of the Brain

Study Results

No Results Posted as of Aug 17, 2009